PAINWeek 2023
9/5/2023 to 9/8/2023
This activity is jointly provided by Global Education Group and PAINWeek

Target Audience
The educational design of this activity addresses the needs of physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other HCPs involved in managing acute and chronic pain.
Statement of Need/Program Overview
PAINWeek provides practical knowledge and tools for healthcare providers managing acute and chronic pain.
Educational Objectives
After completing this activity, the participant should be better able to:
• Explain basic procedures to diagnose and treat acute and chronic pain conditions • Recall interventional neuromodulation-based approaches for pain management
• Describe how marginalized or minority patients present with higher pain prevalence rates and experience less adequate assessment, treatment, and favorable outcomes compared to their majority counterparts
• Describe diagnostic criteria in addition to interventional and pharmacologic approaches for treating acute, chronic, and intractable migraine
• Describe integrative and patient-centered strategies for chronic pain management that incorporate nutrition, acupuncture, and other methods for holistic care
• Identify co-morbid psychiatric conditions associated with chronic pain, and describe techniques for behavioral pain management like cognitive behavioral therapy (CBT) and pain reprocessing therapy (PRT)
• Cite current medical/legal issues impacting pain management, including updated CDC guidelines, and the ethics of consensual/nonconsensual opioid tapering
• Discuss non-opioid therapies for pain management, including efficacy, medication equivalencies, and potential for polypharmacy interactions
Program Agenda
Agenda can be found at www.painweek.org
Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PAINWeek. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this Live Activity for a maximum of 25.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 25.0 MOC points and medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 25 contact hours including pharmacotherapeutic contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Please visit www.painweek.org for pharmacotherapeutic contact hours.
Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Credit Designation
Global Education Group designates this continuing education activity for 25.0 contact hour(s) (2.5 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Numbers can be found at www.painweek.org. This is a knowledge-based activity. Pharmacy Learners: Instructions for Credit – in order to receive credit, pharmacist participants must complete an entire course, complete the posttest and fill out the final evaluation. The final evaluation will be sent to you via email after the conference. Please note that an NABP number and date of birth (MMDD) will be required to earn credit.
Psychology Accreditation Statement
Global Education Group (Global) is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. Global maintains responsibility for this program and its content.
This activity offers a maximum of 25.0 CE for psychologists. The instructional level of this activity is intermediate. Nurse Practitioner Continuing Education

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and PAINWeek. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 25 contact hours(s) which includes pharmacology hour(s). Please visit www.painweek.org for the list of pharmacology hours.
Global Contact Information
For information about the approval of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Instructions for Obtaining Credit
In order to receive credit for this activity, the participant must complete and pass the posttest with a score of at least 70% and complete the evaluation/application for credit. Certificates will then be available for download. Pharmacists: credit will be awarded via CPE Monitor 60 days post the live meeting.
Fee Information& Refund/Cancellation Policy
Please note that there are registration fees that apply to this conference. Refer to www.painweek.org for the cancellation policy.
Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
Faculty list and disclosures provided further in the program guide
The planners and managers at Global Education Group have no relevant financial relationships to disclose. The planners and managers at PAINWeek have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PAINWeek do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.